Canada markets open in 5 hours 24 minutes

Zelira Therapeutics Limited (ZLDAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.48000.0000 (0.00%)
At close: 01:07PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.07M
Enterprise Value 6.16M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)28.86
Price/Book (mrq)0.39
Enterprise Value/Revenue 22.09
Enterprise Value/EBITDA -0.17

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-12.73%
S&P500 52-Week Change 322.38%
52 Week High 31.6500
52 Week Low 30.4704
50-Day Moving Average 30.5146
200-Day Moving Average 30.6548

Share Statistics

Avg Vol (3 month) 357
Avg Vol (10 day) 3N/A
Shares Outstanding 511.35M
Implied Shares Outstanding 611.86M
Float 86.16M
% Held by Insiders 148.71%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:175
Last Split Date 3Apr 14, 2022

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,888.20%

Management Effectiveness

Return on Assets (ttm)-17.89%
Return on Equity (ttm)-242.94%

Income Statement

Revenue (ttm)278.89k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-28.90%
Gross Profit (ttm)N/A
EBITDA -5.14M
Net Income Avi to Common (ttm)-36.43M
Diluted EPS (ttm)-2.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.83k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.73M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.43
Book Value Per Share (mrq)-0.21

Cash Flow Statement

Operating Cash Flow (ttm)-5.38M
Levered Free Cash Flow (ttm)-545.23k